Investment Rating - The report suggests a positive investment outlook for the medical device sector, particularly in brain-computer interface devices, which are expected to see accelerated commercialization due to supportive policies [1][3]. Core Insights - Recent policies have significantly increased support for innovation in medical devices, with the National Medical Products Administration actively promoting faster market entry for brain-computer interface devices, indicating a diverse application landscape and substantial future potential [1][3]. - The pharmaceutical sector is witnessing positive developments, such as GSK's approval of mepolizumab for a new indication in COPD patients, marking it as the first monthly administered biologic in China, which is expected to reduce the annual incidence of severe exacerbations significantly [1][32]. - The report highlights the approval of Wegovy® tablets in the U.S. for weight management, emphasizing its potential impact on the market as the first oral GLP-1 receptor agonist for this purpose [37][40]. Summary by Sections Pharmaceutical Sector - Mepolizumab has been approved for COPD treatment in China, with a monthly dosing schedule, targeting a significant patient population [1][32]. - The A/H share innovation drug sector maintains high activity levels, with new drug approvals and cross-border transactions remaining robust [16][28]. Biologics - Wegovy® tablets have been approved in the U.S. for weight management, showing similar weight loss efficacy to its injectable counterpart, with a significant portion of participants achieving substantial weight loss [37][40]. CXO and Pharmaceutical Supply Chain - The CXO sector continues to show upward momentum, supported by a stable order backlog, with November financing levels slightly above the annual average [44][46]. Medical Devices - The centralized procurement process for high-value medical consumables is progressing steadily, with high selection rates in multiple rounds of bidding, indicating a favorable environment for leading domestic companies [2][52]. Retail Pharmacy - The industry is undergoing a consolidation phase, with leading companies expected to benefit from increased market share through mergers and acquisitions [2][3]. Medical Services and Consumer Healthcare - Aier Eye Hospital's acquisition of 39 institutions for 960 million yuan strengthens its market position, with the acquired entities showing signs of financial recovery [2][3].

Investment Rating - The report suggests a focus on companies such as BYD, Geely Automobile, and others in the automotive sector, as well as companies like Li Auto-W, Xpeng Motors-W, and others in the smart technology and robotics sectors [2]. Core Insights - The Central Economic Work Conference has outlined six key tasks related to the automotive industry, emphasizing domestic demand, innovation, reform, openness, coordinated development, and green transformation, which are expected to stabilize and boost automotive demand [12][13]. - The report highlights that passenger car exports have maintained a year-on-year growth rate of over 20% for six consecutive months, with expectations for double-digit growth in wholesale exports by 2026 due to recovering demand in markets like Russia and the increasing export of new energy vehicles [14]. - The report notes that the smart driving experience is expected to improve significantly with advancements in new architectures and high-performance chips, leading to increased consumer acceptance and sales for leading companies in smart driving technology [17][20]. Industry Data Tracking Market and Sector Performance - The Shanghai and Shenzhen 300 Index increased by 1.95%, while the Shenwan Automotive Index rose by 2.74% [21]. - The top five stocks with the highest gains this week included Chaojie Co. (+41.6%), Longji Machinery (+33.7%), and others, while the top five stocks with the largest declines included Meidong Automotive (-6.5%) and others [28]. Passenger Car Sales Data - In December 2025, the wholesale sales of passenger cars reached 568,000 units, a year-on-year decrease of 9%, while the retail sales were 536,000 units, also down 11% year-on-year [4][32]. - For November 2025, wholesale sales were 2.991 million units, a year-on-year increase of 1.7%, with new energy vehicle wholesale sales at 1.694 million units, up 17.6% year-on-year [5][35]. - The report indicates that the export of passenger cars in November was 594,000 units, reflecting a 50% year-on-year increase, with new energy vehicle exports reaching 273,000 units, up 244.1% year-on-year [51][57]. Industry Dynamics - The report discusses the rapid development of smart technology and robotics, with significant advancements in autonomous driving and AI integration in vehicles, indicating a shift towards a more intelligent automotive market [17][19]. - The report also mentions the increasing focus on new energy vehicles and the expansion of charging infrastructure, which has reached 19.322 million charging points, marking a 52% year-on-year growth [73].

Investment Rating - The report indicates a positive outlook for the petrochemical sector, with various indices showing significant weekly gains, particularly the polyester index which increased by 8.52% [9]. Core Insights - Oil prices experienced fluctuations due to geopolitical tensions and supply concerns, with WTI closing at $56.74 and Brent at $63.73 as of December 26, reflecting a week-on-week increase of $0.59 and $2.30 respectively [15][17]. - The report highlights that the U.S. is focusing on economic measures against Venezuela's oil exports, while tensions in the Gulf region, particularly with Saudi airstrikes in Yemen, contribute to market volatility [17]. - The report notes that the overall oil market remains influenced by geopolitical factors and supply-demand dynamics, with expectations of a potential peace agreement impacting market sentiment [17]. Summary by Sections Market Review - The petrochemical sector outperformed the Shanghai Composite Index, with a weekly increase of 3.18% [9]. - The oil and gas resource index rose by 3.35%, while the refining and chemical index saw a 4.16% increase [9]. Petrochemical Subsector Overview - **Oil**: The report indicates a mixed outlook with oil prices fluctuating due to geopolitical tensions and supply concerns. U.S. crude oil production is reported at 13.84 million barrels per day, with a decrease in net imports [15]. - **Refining**: The average refining margin for major refineries was reported at 663.63 yuan/ton, showing an increase of 49.75 yuan/ton from the previous period [15]. - **Polyester**: The report notes that polyester production is facing challenges with profitability, as the average profit for polyester POY150D was reported at -135.19 yuan/ton [15]. - **Olefins**: Ethylene prices remained stable at 6172 yuan/ton, while propylene prices decreased by 240 yuan/ton to 5715 yuan/ton [15]. Price Tracking - The report provides detailed tracking of various petrochemical product prices, indicating significant fluctuations in margins and costs across different segments [12][14].

Investment Rating - The report does not explicitly state an investment rating for the industry. Core Insights - The dexterous hand is a high-degree-of-freedom robotic end effector that mimics human hand functionality, providing flexibility and adaptability that surpass traditional mechanical grippers. It is a critical component of humanoid robots, accounting for approximately 20%-30% of the total cost of the robot. The future value of humanoid robots will largely depend on the dexterous hand's flexibility and collaborative capabilities [4][5]. Summary by Sections 1. Key Technologies and Comparison of Dexterous Hands - The design of dexterous hands is inspired by the complex structure and functionality of human hands, enabling robots to perform diverse tasks such as grasping and manipulation. A typical dexterous hand system consists of four key components: drive system, transmission system, sensor system, and control system [13][14]. - The trend in dexterous hand technology is towards electric drive systems combined with composite transmission and tactile sensing [14][22]. 2. Drive Devices: Domestic Competitive Advantages - Electric motor drives are the mainstream technology due to their precision and cost-effectiveness. The report highlights that the demand for motors will increase with the rise in degrees of freedom in dexterous hands, presenting market opportunities for suppliers of hollow cup motors and brushless gear motors [5][22]. 3. Transmission Methods: Ball Screw Advantages - The report indicates that ball screw transmission is becoming a dominant trend in dexterous hand design due to its high load-bearing capacity and precision, making it suitable for industrial applications [35][41]. 4. Sensors: Increasing Sensor Count - The report notes that the number of sensors in dexterous hands is on the rise, with various types including tactile, force, and position sensors being utilized to enhance interaction with external objects [47][52]. 5. Dexterous Hands and Related Industry Chain - The dexterous hand represents a high-value component with significant barriers to entry, indicating a robust market potential for companies involved in its development and production [5][44].

Investment Rating - The report maintains a "Buy" rating for the home appliance industry, expecting a price increase exceeding 15% over the next 3-6 months compared to the market [42]. Core Insights - The report highlights a rebound in air conditioner production in January 2026 due to a shift in production schedules, although end-user demand is expected to remain weak. Home air conditioner domestic production reached 7.86 million units, up 8.9% year-on-year, while export production was 10.65 million units, up 1.2% year-on-year [13][14]. - Refrigerator production showed a decline in both domestic and export markets, with domestic production at 3.52 million units, down 6.9% year-on-year, and export production at 4.4 million units, down 3.4% year-on-year. The market is experiencing regional differentiation, with emerging markets being the main growth points [16]. - Washing machine production also faced challenges, with domestic production at 3.65 million units, down 4.1% year-on-year, and export production at 4.45 million units, down 0.7% year-on-year. The "trade-in" policy's effectiveness is diminishing, and companies need to innovate to find breakthroughs [17]. Market and Sector Performance - The Shanghai and Shenzhen 300 Index increased by 1.95%, while the home appliance index rose by 0.54%. Notable stock performances included Feike Electric (+24.57%), Jinhai High-Tech (+22.57%), and Tianyin Electromechanical (+17.91%) [20]. - The report tracks raw material prices, noting a 2.62% increase in copper prices and a 1.16% increase in aluminum prices, while cold-rolled steel and plastic prices saw slight declines [24]. - The exchange rate for USD to RMB was reported at 7.04, with a slight decrease of 0.02% week-on-week, and container shipping rates showed a small increase of 1.95% [27]. Real Estate Data - Real estate data for November 2025 indicates a significant decline in new construction, with a year-on-year decrease of 20% in new starts, 10% in construction, and 20.2% in completions. Sales also fell by 8.9% year-on-year, indicating ongoing pressure on the home appliance sector's long-term demand [31][32]. Investment Recommendations - The report suggests that leading brands are likely to achieve stable growth due to their integrated advantages and strong pricing power. The external market is expected to benefit from a potential recovery in the U.S. housing market and gradual improvement in European consumption. Emerging markets are anticipated to maintain strong demand due to demographic advantages [40]. Recommended companies include Hisense, Midea Group, Haier, and TCL Electronics [40].

Investment Rating - The report suggests a positive outlook for the pharmacy and traditional Chinese medicine sectors, anticipating a recovery in 2026 after a weak performance in 2025 [2][5]. Core Insights - The pharmacy sector is expected to benefit from market consolidation, with leading companies likely to increase their market share through mergers and acquisitions during the industry clearing phase [3][11]. - The traditional Chinese medicine sector is projected to stabilize and potentially recover, driven by an increase in flu incidence and the upcoming update of the essential drug list [57][60]. Summary by Sections Pharmacy Sector - **Market Review**: The pharmacy sector faced significant challenges in 2025, with a decline in same-store sales and an overall reduction in the number of operating stores since Q4 2024 [5][20]. - **Policy Environment**: Regulatory measures are promoting a more compliant and healthier industry ecosystem, which is expected to benefit leading companies [14][15]. - **Market Size**: In the first ten months of 2025, the sales scale of physical pharmacies was 501.3 billion yuan, a year-on-year decrease of 1.6%, primarily due to a decline in non-pharmaceutical sales [16][21]. - **Competitive Landscape**: The number of pharmacies in China reached approximately 684,000 by the end of 2024, with a notable increase in store closures, particularly among smaller chains [20][24]. - **Marginal Performance**: There has been a slight recovery in retail sales data, with leading companies showing improved performance through cost reduction and efficiency measures [32][34]. - **Outlook for 2026**: Focus on market consolidation and the development of non-pharmaceutical products is recommended, as leading companies are expected to enhance their market share [44][52]. Traditional Chinese Medicine Sector - **Market Review**: The traditional Chinese medicine sector experienced overall weak performance in 2025, with some companies seeing temporary valuation increases due to innovative pipelines [57][58]. - **In-Hospital Opportunities**: The upcoming update of the essential drug list is expected to benefit companies with products that have the potential to be included [60]. - **Out-of-Hospital Opportunities**: An increase in flu incidence in Q4 2025 is anticipated to aid in inventory digestion, with some companies expected to see improved performance [60]. - **High Dividend Stocks**: Companies such as Lingrui Pharmaceutical, Jichuan Pharmaceutical, and Dong'e Ejiao are highlighted as stable high-dividend investment opportunities [60].

Investment Rating - The report suggests a positive outlook for the high-end equipment manufacturing industry in China, emphasizing a "dual-driven" growth model characterized by strong domestic demand and robust international expansion [3][5]. Core Insights - The high-end equipment industry in China is experiencing a structural transformation, with a focus on technological advancements and brand development, leading to increased global market share [3]. - The report highlights two main investment themes: the technological self-reliance driven by AI and the deepening international expansion of Chinese equipment manufacturers [4][5]. - Key sectors to watch include gas turbines, industrial mother machines, controlled nuclear fusion, quantum computing, robotics, and 3D printing, which are expected to drive future growth [4][41]. Summary by Sections Domestic Manufacturing and Investment - Manufacturing investment in China is under short-term pressure, but high-end manufacturing and equipment sectors are emerging as growth engines, with a 1.9% year-on-year increase in manufacturing fixed asset investment [15][19]. - The report notes that high-tech manufacturing and equipment manufacturing sectors maintain high levels of activity despite overall investment slowdowns [15][22]. Export Performance - China's high-end equipment exports are performing well, driven by the global AI investment boom and recovery in demand from developed markets [28][31]. - In the first ten months of 2025, China's exports of electromechanical products reached 13.43 trillion yuan, marking an 8.7% year-on-year increase [28][31]. Technological Self-Reliance - The report emphasizes the importance of technological self-reliance, particularly in sectors like gas turbines and quantum computing, which are expected to see significant growth due to increasing global demand [4][48]. - The global gas turbine market is projected to grow significantly, with sales expected to rise from 44.1 GW in 2023 to an average of 60 GW from 2024 to 2026, reflecting a 36% increase [49][50]. International Expansion - Chinese equipment manufacturers are poised for further international growth, particularly in emerging markets, with sectors like engineering machinery and agricultural equipment expected to see substantial export growth [5][41]. - The report highlights the potential for Chinese companies in the oil and gas equipment sector, particularly in the Middle East, where demand is expected to rise significantly [5][13].

- The quantitative index enhancement market has seen rapid growth, expanding from 95.85 billion yuan in 2020 to over 250 billion yuan by 2025[2][14] - The market is characterized by a concentration of top products and an increase in average scale, with leading products continuously breaking new ground[2] - Regulatory policies starting in 2024 have compressed the alpha space for high-frequency T0 strategies, pushing managers to shift from high-frequency trading to mid-to-low-frequency fundamental factor exploration[2] - The average turnover rate of products has generally decreased since 2025, and the quality of index constituent stocks has improved, transforming quantitative index enhancement from a short-term trading tool to a product with long-term asset allocation value[2] - Yongying Fund Management Co., Ltd. is a joint venture fund company established by Ningbo Bank and OCBC Bank, with a management scale exceeding 620 billion yuan as of Q3 2025[3] - Yongying's quantitative index enhancement product system is divided into three categories: regular broad-based index enhancement, special benchmark index enhancement, and quantitative theme index enhancement[3] - The system relies on three core capabilities: full-process application of machine learning, multi-strategy integration, and strict risk control, ensuring stable excess returns and risk control in different market environments[3] - Yongying SSE STAR 100 Index Enhancement A (021278) is an enhanced index product with a stock position maintained above 90% since its inception, showing higher volatility and drawdown compared to similar products but better return performance[4] - Yongying CSI A50 Index Enhancement A (022204) is another enhanced index product with lower volatility and drawdown levels compared to similar products, and better return performance, reflecting good risk-adjusted returns[5]

Investment Rating - The report suggests that the domestic HNB (Heated Not Burned) industry is on the verge of significant growth, driven by international tobacco giants shifting towards new tobacco products [5]. Core Insights - The global cigarette market is experiencing an irreversible decline, with smoking rates dropping from 30.75% in 2005 to 21.74% in 2022, and cigarette market size decreasing from 53,908 billion sticks in 2018 to an estimated 51,561 billion sticks in 2024, reflecting a CAGR of -0.74% [1][13]. - Major tobacco companies, including Philip Morris International (PMI), are focusing on new tobacco products as a core growth driver, with PMI planning for over two-thirds of its revenue to come from new tobacco products by 2030 [1][20]. - The Japanese market serves as a reference point, showing that the rapid penetration of heated tobacco products has not negatively impacted tax revenues, with the market size growing from 37.28 billion sticks in 2019 to 64.50 billion sticks in 2024, a CAGR of 11.59% [2][51]. Summary by Sections Section 1: HNB as a Core Development Category - International tobacco giants are increasingly focusing on new tobacco products as a long-term performance core, with significant contributions to profitability [1.1]. - The global market for heated tobacco and electronic cigarettes is projected to grow, with sales expected to reach $38.85 billion and $23.04 billion respectively by 2024, reflecting growth rates of 12.7% and 9.5% [1.1][13]. Section 2: Domestic Tobacco Industry Challenges - The traditional cigarette market in China is under pressure, with production increasing from 23,642 billion sticks in 2019 to 24,655 billion sticks in 2024, but at a slowing growth rate [3][55]. - The inventory levels in the tobacco industry have risen significantly, from 150 billion yuan in 2010 to approximately 4,394 billion yuan in 2024, indicating a high stock level [3][56]. Section 3: Regulatory Framework for HNB - The regulatory landscape for heated tobacco products is becoming clearer globally, with established frameworks in the US, Japan, and Europe, providing a roadmap for compliance [4][62]. - The US has implemented a structured regulatory process for HNB products, which includes pre-market tobacco application (PMTA) requirements, ensuring a predictable compliance environment [4][66]. Section 4: Domestic Product Development and Market Readiness - Chinese tobacco companies have made significant strides in developing HNB products, with several companies launching domestic HNB devices and achieving a substantial number of patents in the field [4][5]. - The report emphasizes the importance of product innovation and international expansion for the high-quality development of the domestic tobacco industry [3][5]. Section 5: Company Analysis - Companies like Huabao International and Smoore International are highlighted for their strong technical reserves and potential for growth in the HNB sector, with Huabao expected to benefit from its leading position in the flavoring segment [5][5.1][5.2].

1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints - According to Wind data, among the bonds traded at a discount, "24 Chengtong Holdings MTN010B" had a relatively large deviation in valuation price; among the bonds with rising net prices, "Jingzi K10" led in terms of valuation price deviation; among the Tier 2 and perpetual bonds with rising net prices, "25 Ping An Bank Perpetual Bond 01BC" showed a relatively large deviation in valuation price; among the commercial financial bonds with rising net prices, "25 Zhangjiagang Rural Commercial Science and Technology Innovation Bond 01" ranked high in terms of valuation price deviation; among the bonds with a trading yield higher than 5%, transportation bonds were at the forefront [2]. - The changes in credit bond valuation yields are mainly distributed in the [-5,5] range. The trading terms of non - financial credit bonds are mainly between 2 and 3 years, with the highest proportion of discount - traded varieties within 0.5 years; the trading terms of Tier 2 and perpetual bonds are mainly between 4 and 5 years, with the highest proportion of discount - traded varieties between 1 and 3 years. By industry, the bonds in the light manufacturing industry had the largest average deviation in valuation price [2]. 3. Summary by Relevant Catalogs 3.1 Discounted Bond Trading Tracking - The report tracked the trading of significantly discounted bonds, listing the remaining term, valuation price deviation, valuation net price, valuation yield deviation, valuation yield, previous - day valuation yield, implied rating, subject rating, industry, and trading volume of various bonds such as "24 Chengtong Holdings MTN010B" [4]. 3.2 Tracking of Bonds with Rising Net Prices - It tracked the trading of bonds with significant positive deviations in net prices. Bonds like "Jingzi K10" had a valuation price deviation of 0.21%, and the report also provided details on other bonds including remaining term, valuation price deviation, etc. [5]. - For Tier 2 and perpetual bonds with rising net prices, "25 Ping An Bank Perpetual Bond 01BC" and others were listed, with a valuation price deviation of about 0.03% for many of them [6]. 3.3 Commercial Financial Bond Trading Tracking - The trading of commercial financial bonds was tracked, such as "25 Zhangjiagang Rural Commercial Science and Technology Innovation Bond 01", with information on remaining term, valuation price deviation, etc. provided [9]. 3.4 Tracking of Bonds with a Trading Yield Higher than 5% - Bonds like "24 Ruimao 02" with a trading yield higher than 5% were tracked, and the report presented details such as remaining term, valuation price deviation, and trading volume [10]. 3.5 Distribution of Credit Bond Trading Valuation Deviations on the Day - The distribution of changes in credit bond valuation yields on the day was mainly in the [-10,-5), [-5,0), (0,5], (5,10] intervals, along with the number of bonds and trading volume [13]. 3.6 Distribution of Trading Terms of Non - Financial Credit Bonds on the Day - The trading terms of non - financial credit bonds (including urban investment and industrial bonds) on the day were mainly between 2 and 3 years, with corresponding trading volumes [15]. 3.7 Distribution of Trading Terms of Tier 2 and Perpetual Bonds on the Day - The trading terms of Tier 2 and perpetual bonds on the day were mainly between 4 and 5 years, with relevant trading volume data [18]. 3.8 Discounted Trading Ratio and Trading Volume of Non - Financial Credit Bonds by Industry - The average valuation price deviation and trading volume of non - financial credit bonds in various industries were presented, with the light manufacturing industry having the largest average valuation price deviation [20].